|
|
|
Volumn 20 Suppl C, Issue , 2004, Pages
|
|
Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACRYLIC ACID DERIVATIVE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
EPROSARTAN;
HYDROCHLOROTHIAZIDE;
IMIDAZOLE DERIVATIVE;
THIOPHENE DERIVATIVE;
AGED;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
CANADA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLE;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
HYPERTENSION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PRIMARY HEALTH CARE;
PROBABILITY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REFERENCE VALUE;
SINGLE BLIND PROCEDURE;
SYSTOLE;
TREATMENT OUTCOME;
ACRYLATES;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
BLOOD PRESSURE DETERMINATION;
CANADA;
DIASTOLE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYDROCHLOROTHIAZIDE;
HYPERTENSION;
IMIDAZOLES;
MALE;
MIDDLE AGED;
PRIMARY HEALTH CARE;
PROBABILITY;
PROSPECTIVE STUDIES;
REFERENCE VALUES;
SEVERITY OF ILLNESS INDEX;
SINGLE-BLIND METHOD;
SYSTOLE;
THIOPHENES;
TREATMENT OUTCOME;
|
|
EID: 36849081732
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
